| |
 |
Only CUBICIN is indicated for S. aureus bacteremia |
 |
Clinicians have treated more than 500,000 patients*
with CUBICIN, inside and out |
 |
Discharge patients on CUBICIN, the only once daily
option for MRSA skin and bacteremia |
|
| |
*Estimated number of patients treated based on sales
through March 2008. |
|
|

These online forums feature thought leaders, offering physicians expert insight and strategies for managing S. aureus bacteremia and complicated skin infections. This educational service is designed to keep you and your colleagues prepared to fight MRSA bacteremia and complicated skin infections. Click to access this online forum of thought leaders.
|